The mechanism of its ameliorating action on BPH was reported as its specific binding to 5α-DHT by sequestering 5α-DHT from the androgen receptor, thus decreasing androgen hormone actions to improve prostate health by acting as a selective androgen modulator (Edwin, 2014). The gene discussed is AR; the disease is benign prostatic hyperplasia.